Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Concern for Structural Changes in Covid19 variants

Comeback of tuberculosis- but its drug-resistant now!

BITFAM infers transcription factor activity in individual cells

Concern for Structural Changes in Covid19 variants
  • BiotechToday
  • World

Concern for Structural Changes in Covid19 variants

DNA tales July 3, 2021July 2, 2021

Sribas Chowdhury, Adamas University Kolkata

We all know how the horrific Covid19 pandemic has shaken the entire world. With the SARS-corona virus, 2 is the main culprit, it has claimed millions of lives worldwide and has disrupted the socio-economic balance of all countries. The virus has been a cause of concern due to its variants rising very frequently in spite of it having a low mutation rate. These variants spread at a much faster rate and are speculated to be more potent than the ones that originated in Wuhan. This made the process of vaccine making and vaccination drive particularly challenging in countries across the world.

However, recent studies show that situations may or may not take a turn for the worse. Scientists at Boston Children’s Hospital examined the Alpha and Beta variant of the SARS Cov-2 virus. The study, led by a team under Dr Bing Chen, was carried on using the cryo-EM technique to observe the spike protein of the virus.

It all starts with the ‘Spike Protein’

Spike proteins are very crucial towards spreading and infection of the virus. These proteins are present on the surface of the virus and help the cell wall of the virus to fuse with the cell wall of the target cell. Then, the viral DNA enters the cell and infects it. Most available vaccines are directed towards releasing antibodies that can neutralize these spike proteins. The study was conducted to observe the difference in structural changes of the spike protein in Alpha and Beta variants from the original virus.

The Beta version (also known as B.1.351) showed mutations in which the shape of the spike proteins got changed in some areas. As a result, the efficiency of neutralizing antibodies stimulated by the vaccine showed a decrement. This raised concerns as it indicated that the variant may dodge the immune system, even in vaccinated people. However, it was also found out that this variant was less transmissible, due to the mutation decreasing the ability of spike protein to bind to ACE2 receptors.

The Alpha version showed mutations that made it more infectious. A mutation in the form of a single amino acid substitution in its spike protein made it more susceptible to binding with ACE2 receptors. This could have led to the alpha version being more transmissible across the general population. Fortunately, test results indicated that the existing vaccines can be effective against these as the antibodies induced by them are still efficient against this variant.

What to make of the spike protein mutations?

The scientists are confident that the changes in these two variants aren’t much of a threat as both the variants didn’t meet the criteria to qualify as a heightened threat. But, they have also indicated that the most troublesome combination hasn’t been found yet and so further investigation is necessary. The team plans to study the other variants like the concerning Delta variant (names B.1.617.2) and publish the results of their investigation in near future. Further investigations can reveal more about the working mechanism of the virus and can lead to better understanding and ideation of methods and solutions to curb the spreading of the life-threatening disease and eradicate it entirely.

Also read: IgA-virus Immune Complex: Neutrophil’s trap for SARS-CoV-2

Reference:

  1. Cai, Y., Zhang, J., Xiao, T., Lavine, C. L., Rawson, S., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A., Lu, S., Sterling, S. M., Walsh, R. M., Rits-Volloch, S., Lu, J., Wesemann, D. R., Yang, W., Seaman, M. S., & Chen, B. (2021). Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science. https://doi.org/10.1126/science.abi9745
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ACE2 alpha variant B.1.351 B.1.617.2 beta variant COVID19 delta variant DNA Molecular biology Mutations pandemic Protein research spike protein VACCINE vaccine development variant virus

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

BITFAM infers transcription factor activity in individual cells

bioxone July 3, 2021

Monika R, PSG College of Technology, Coimbatore Transcriptional gene regulation is how a cell regulates the conversion of DNA to RNA, and it is also a complex process that utilizes a network of interactions. This process is primarily controlled by DNA binding proteins known as transcription factors (TFs)/regulators, that attach to specific DNA sequences and thereby repress […]

BITFAM

Related Post

  • BiotechToday
  • World

A dash of sugar kelp for better health

bioxone June 28, 2021June 27, 2021

Avani Dave, Jai Hind College “Looks can be deceiving” and the exhibits are seaweeds. This name paints a canvas of a beautiful beach and a bunch of unusual plant-like strands washed straight to the shore. Consuming seaweed as a source of nutrition has received fame around some parts of the globe. UConn researchers decided to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

DRDO’s “2-DG” Anti-Covid Drug has been finally launched

bioxone May 18, 2021May 18, 2021

Anuska Sen, Team BioXone Abbreviations used in the following article: 2-DG: 2-deoxy-D-glucose DRDO: Defence Research and Development Organization INMAS: Institute of Nuclear Medicine and Allied Sciences DCGI: Drugs Controller General of India The 2-DG anti-covid drug jointly developed by DRDO’s INMAS laboratory and Dr. Reddy’s Laboratories has finally been launched yesterday (Monday, 17th May, 2021). […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Effect of glucocorticoid treatment in early Rheumatoid Arthritis

BioTech Today July 9, 2021July 8, 2021

Sayak Banerjee, Amity University Kolkata Rheumatoid Arthritis and osteoporosis: Rheumatoid Arthritis (RA) is a chronic systemic inflammatory disease that mostly occurs in synovial joints. Its symptoms are local bone loss depicted by juxta-articular osteoporosis, and systemic bone loss depicted by generalized osteoporosis. Among these two symptoms, generalized osteoporosis is more common in patients with RA […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy